Fidelity Health Services are frontline adopters in technology-based solutions for our clients. By combining high-end Technologies with skilled human resources & smart processes, our pharmaceuticals, biopharma & life sciences clients are effectively advancing discoveries, and are delivering solutions that make a difference in patients’ lives.

Post : Senior Executive, Medical Knowledge Management

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Position : Senior Product Manager / Group Product Manager-Veterinary

Lupin Diagnostics Limited is a 100% subsidiary of Lupin Limited. The company is headquartered in Mumbai with National Reference Laboratory in Navi Mumbai. All the processing laboratories are operated by Lupin Diagnostics as a hub and spoke model. It includes Collection Centres, Pick-up Points, Hospital Laboratory Management, Retail Laboratory Management, and Home Collection pan-India.

Post : Officer / Jr. Officer (Analyst) - Quality Control

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

HETERO – Walk-In Interview for FRESHERS QA / QC  on 14th Dec’ 2022 at Hyderabad

Stallion Headquartered in Ahmedabad (India) along with three Overseas offices in Vietnam, Nigeria and Angola for its international operations.  Stallion manufactures a wide range of pharmaceuticals, across the broad spectrum of therapies which includes Antidiabetics, Cardiovascular, Urology, Antibiotics – Antibacterial, Gastrointestinal, Cough & Cold, Anxiolytics & Antidepressants, Analgesics –Anti-Inflammatories, Antivirals, Antifungals, Anthelminthic, Anti protozoal, Antimalarial, Antihistaminic, Nutritional supplements and others.

Incorporated in 1996, SIRO Clinpharm Private Limited is a Clinical Research Organisation supporting trials from Phase II to Phase IV and beyond post-launch of products. SIRO offers a range of services, from clinical operations to data services, data analytics and medical writing in compliance with international standards.   SIRO has been an industry pioneer over two decades, sharing an incontestable record of excellence in the pharmaceutical, FMCG and medical device industry.

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers from Penn Medicine’s Abramson Cancer Center showed, suggesting the drug is a strong candidate for clinical trials. The study was published today in Cancer Discovery, a journal of the American Association for Cancer Research.

Preventing metastasis – the development of cancer cells beyond their original location – remains one of the major goals of current cancer research. Most malignant tumor cells metastasize by exploiting abnormal leakage from blood vessels. New work looks to further explore the role of how the alignment of endothelial cells, which line blood vessels, plays a role in the spread of cancer.

Pfizer Inc and BioNTech SE announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. With the high level of respiratory illnesses currently circulating among children under 5 years of age, updated COVID-19 vaccines may help prevent severe illness and hospitalization.

Union Minister of State (Independent Charge) Science & Technology, Dr Jitendra Singh said, India will make significant investment in R&D to develop a roadmap for design and delivery of vaccine development for future pandemic.

Our Educational Organization Maharishi Parshuram College of Pharmacy is a premier College in Fazilka Punjab (Running D-Pharmacy) with academic excellence Maharishi Parshuram College of Pharmacy is approved by AICTE, PCI New Delhi and Govt. of Punjab.

HOD/ Principal of Diploma Pharmacy College
Qualification – M.Pharma with 5 yrs experience 

Jawaharlal Nehru Centre for Advanced Scientific Research is an autonomous institution that was established in 1989 by the Department of Science and Technology, GoI to commemorate the birth centenary year of Pandit Jawaharlal Nehru. Bharat Ratna Prof. C. N. R. Rao, FRS, was the founding President. The Centre was registered as a society with Dr. Raja Ramanna (eminent physicist and Former Chairman, DAE) as its first Chairman.

Post : Research Associate

Advanced Centre for Treatment, Research and Education in Cancer, ACTREC, is a unique Institute under the wing of Tata Memorial Centre and a grant-in-aid Institution of the Department of Atomic Energy. ACTREC conducts a PhD program in Life Sciences that is affiliated with the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt. of India). Fulfilling its ‘bench-to- bedside’ mandate, the Institute provides a highly conducive environment for world-class cancer research.

The National Institute of Biologicals (NIB) had been set up in 1992. NIB is an apex autonomous institute under the administrative control of Ministry of Health & Family Welfare (MoHFW), Government of India. The Institute is performing primary statutory function of Quality Control of Biologicals e.g. Insulin, erythropoietin, blood products, diagnostic kits e.g. HIV, HBV, HCV, therapeutic monoclonal antibodies like Trastuzumab and Rituximab used in cancer treatment etc.

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from eligible Indian Nationals for the following project positions.

Project Title : “Mission Program on Pediatric Rare Genetic Disorders” (Funded by DBT)
Principal Investigator : Dr. P V Ramchander* & Dr. R. Swain**

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field. 

Post : Senior Executive - NCQ

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Unit dealing in regulated markets having approval like MHRA, TGA & GLC etc.

OPEN POSITIONS for Formulation Site

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.